Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages

Virology

Volumn 390, Issue 1, 2009, Pages 37-44

  Mikulak, Joanna ^a   Gianolini, Monica ^a   Versmisse, Pierre ^b   Pancino, Gianfranco ^b   Lusso, Paolo ^a,c   Verani, Alessia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Bacterial endotoxin; HIV 1; Innate immunity; Macrophages

Indexed keywords

ALPHA DEFENSIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLOHEXIMIDE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 16; LIPOPOLYSACCHARIDE; MACROPHAGE DERIVED ANTI HUMAN IMMUNODEFICIENCY VIRUS FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEINASE K; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC DIFFERENCE; HEAT SENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SECRETION; VIRUS ENTRY; VIRUS STRAIN;

ANTI-HIV AGENTS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOHEXIMIDE; CYTOKINES; DNA PRIMERS; DNA, VIRAL; HIV-1; HUMANS; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-TYROSINE KINASES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 67649482340     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.04.005     Document Type: Article

References (34)

1. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., and Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086-3093
2. Alfano M., Sidenius N., Blasi F., and Poli G. The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection. J. Leukoc. Biol. 74 (2003) 750-756
3. Baba M., Nishimura O., Kanzaki N., Okamoto M., Sawada H., Iizawa Y., Shiraishi M., Aramaki Y., Okonogi K., Ogawa Y., Meguro K., and Fujino M. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5698-5703
4. Barton G.M., and Medzhitov R. Toll-like receptor signaling pathways. Science 300 (2003) 1524-1525
5. Bernstein M.S., Tong-Starksen S.E., and Locksley R.M. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. J. Clin. Invest. 88 (1991) 540-545
6. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115 (1991) 457
7. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
8. Chang T.L., Francois F., Mosoian A., and Klotman M.E. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J. Virol. 77 (2003) 6777-6784
9. Chen L.Y., Zuraw B.L., Zhao M., Liu F.T., Huang S., and Pan Z.K. Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes. Am. J. Physiol., Lung Cell. Mol. Physiol. 284 (2003) L607-613
10. Cotter R.L., Zheng J., Che M., Niemann D., Liu Y., He J., Thomas E., and Gendelman H.E. Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry. J. Virol. 75 (2001) 4308-4320
11. Franchin G., Zybarth G., Dai W.W., Dubrovsky L., Reiling N., Schmidtmayerova H., Bukrinsky M., and Sherry B. Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 164 (2000) 2592-2601
12. Furci L., Sironi F., Tolazzi M., Vassena L., and Lusso P. Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood 109 (2007) 2928-2935
13. Geng Y., Zhang B., and Lotz M. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151 (1993) 6692-6700
14. Haziot A., Ferrero E., Köntgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., and Goyert S.M. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4 (1996) 407-414
15. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J. Immunol. 162 (1999) 3749-3752
16. Kedzierska K., and Crowe S.M. Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12 (2001) 133-150
17. Kornbluth R.S., Oh P.S., Munis J.R., Cleveland P.H., and Richman D.D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169 (1989) 1137-1151
18. Lusso P. HIV and the chemokine system: 10 years later. EMBO J. 25 (2006) 447-456
19. Mackewicz C.E., Yuan J., Tran P., Diaz L., Mack E., Selsted M.E., and Levy J.A. alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 17 (2003) F23-32
20. Marzio P.D., Sherry B., Thomas E.K., Franchin G., Schmidtmayerova H., and Bukrinsky M. Beta-Chemokine production in CD40L-stimulated monocyte-derived macrophages requires activation of MAPK signaling pathways. Cytokine 23 (2003) 53-63
21. O'Doherty U., Swiggard W.J., and Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74 (2000) 10074-10080
22. Perez-Bercoff D., David A., Sudry H., Barre-Sinoussi F., and Pancino G. Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 77 (2003) 4081-4094
23. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
24. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zahringer U., Seydel U., Di Padova F., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8 (1994) 217-225
25. Shames B.D., Selzman C.H., Pulido E.J., Meng X., Meldrum D.R., McIntyre Jr. R.C., Harken A.H., and Banerjee A. LPS-induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. J. Surg. Res. 83 (1999) 69-74
26. Shapira L., Takashiba S., Champagne C., Amar S., and Van Dyke T.E. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes. J. Immunol. 153 (1994) 1818-1824
27. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
28. Trabattoni D., Caputo S.L., Maffeis G., Vichi F., Biasin M., Pierotti P., Fasano F., Saresella M., Franchini M., Ferrante P., Mazzotta F., and Clerici M. Human alpha defensin in HIV-exposed but uninfected individuals. J. Acquir. Immune Defic. Syndr. 35 (2004) 455-463
29. Triantafilou M., and Triantafilou K. The dynamics of LPS recognition: complex orchestration of multiple receptors. J. Endotoxin Res. 11 (2005) 5-11
30. Verani A., Scarlatti G., Comar M., Tresoldi E., Polo S., Giacca M., Lusso P., Siccardi A.G., and Vercelli D. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185 (1997) 805-816
31. Verani A., Sironi F., Siccardi A.G., Lusso P., and Vercelli D. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes. J. Immunol. 168 (2002) 6388-6395
32. Verani A., Gras G., and Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol. Immunol. 42 (2005) 195-212
33. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
34. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmasso E.A., Fu S., Pham T., Mei J., Ho J.J., Zhang W., Lopez P., and Ho D.D. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298 (2002) 995-1000